Ignatko Irina Vladimirovna (RU),Игнатко Ирина Владимировна (RU),Rodionova Aleksandra Mikhajlovna (RU),Родионова Александра Михайловна (RU)
申请号：
RU2018147168
公开号：
RU0002702448C1
申请日:
2018.12.28
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to obstetrics and perinatology and can be used in managing patients with fetal arrhythmia (FA). Gestation period is determined. Presence/absence of the effect of the conducted treatment is detected, and the FA course is complicated/uncomplicated by the onset of heart failure. Type of FA is also determined: organic FA, if observing organic changes of fetal heart, or functional FA, at normal fetal heart structure. On 22–27 week of pregnancy, the organic and functional FA consistently perform a perinatal consultation, conservative therapy, expectant management, delivery through natural birth canals. At period of 28–33 weeks in the case of uncomplicated FA with organic FA, the perinatal consultation, conservative treatment, actively wait-and-see approach are sequentially. Functional PA is preceded by a perinatal consultation, a conservative treatment of 72 hours, in the absence of the effect of which - a Cesarean section. At period of 28–33 weeks in case of complicated FA with organic FA, complex therapy is performed for 72 hours, and in case of no effect – Cesarean section. Functional FA is followed by a cesarean delivery. At 34 weeks and more, in case of uncomplicated FA with organic FA, conservative treatment is performed within 72 hours, and in case of no effect – Cesarean section. Functional CA is followed by a cesarean delivery. At the gestational age of 34 weeks and more in the case of complicated FA with organic and functional FA, the Cesarean section is performed.EFFECT: method enables reducing perinatal morbidity and mortality by evaluating a complex of the most significant factors.1 cl, 4 tbl, 2 exИзобретение относится к области медицины, а именно к акушерству и перинатологии и может быть использовано при ведении пациенток с фетальной аритмией (ФА). Определяют срок беременности. Выявляют наличие/отсутствие эффекта от проводимого лечения, осложненный/неосложненный возникновением сердечной недостат
